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Case Report 
Inaccuracy of Fine-needle Biopsy in the Diagnosis of
Solitary Fibrous Tumour of the Liver
Jane Jingyao Chen, Seok Ling Ong, Cathy Richards, Giuseppe Garcea, Cristina Pollard, David Berry and 
Ashley Dennison, Department of Hepatobiliary and Pancreatic Surgery, Leicester General Hospital, 
Leicester, UK.
Solitary fibrous tumour (SFT) is an uncommon neoplasm of mesenchymal origin that primarily affects
the pleura and mediastinum. SFTs may occur elsewhere in the body including the liver, peritoneum, orbit
and other soft tissues. Recent advances in immunohistochemical analysis have allowed greater identification
of SFTs. Nevertheless, radiologically it remains difficult to distinguish SFTs of the liver from other solitary
tumours as they have many common features. We report a case of SFT of the liver and highlight the
potential inaccuracy of percutaneous biopsy in the diagnosis of large solitary liver tumours. [Asian J Surg
2008;31(4):195–8]
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Introduction
Solitary fibrous tumour (SFT) is an uncommon neoplasm
of mesenchymal origin that primarily affects the pleura
and mediastinum. Recent advances in immunohisto-
chemical analysis have resulted in greater identification
of SFTs at other sites including the peritoneum, orbit and
soft tissues.1–8 SFTs remain difficult to diagnose as con-
ventional laboratory and radiological findings are often
nonspecific and unable to provide information about
malignant potential.3 Here, we discuss the clinical manage-
ment of an SFT of the liver and illustrate the difficulties
with radiological diagnosis.
Case report
A 71-year-old man underwent right hemicolectomy for 
a Dukes’ B (T3N0Mx) adenocarcinoma of the caecum.
Computed tomography (CT) performed during routine
follow-up revealed a right subhepatic mass. Whole-body
fluorodeoxyglucose positron emission tomography (PET)
showed that the mass had low metabolic activity, and was
therefore likely to be benign. There was no evidence of
recurrent or metastatic disease. Percutaneous CT-guided
Tru-cut needle biopsy of the mass was performed at the
referring centre, and histology demonstrated features of 
a well-differentiated adenocarcinoma with fibroblastic
stroma (Figure 1). It was felt that the most likely origin
was a pancreatic or upper gastrointestinal tract (GI) pri-
mary tumour, which was not related to the previously
excised colorectal adenocarcinoma. Upper GI endoscopy
was normal and the patient was subsequently referred to
our department for a specialist opinion and for manage-
ment of the mass. A repeat CT scan demonstrated a large,
heterogeneous mass in segments VI/VII of the liver, which
measured 9.5 cm in diameter (Figures 2 and 3). The patient
underwent a thorough laparotomy, which was completely
normal apart from the known mass, and was treated by
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resection of segments VI/VII. The patient’s postoperative
course was uneventful, with no evidence of recurrence 
9 months after surgery, and is being followed up with 
regular CT scans.
Macroscopically, the tumour was firm, white and
bosselated, and measured 87 × 55 × 85 mm, with a central
cystic area that distended the capsular surface of the liver.
Histological examination showed a patternless spindle-
cell tumour with variable cellularity and a mitotic index
of six mitoses per 50 high-power fields (hpf). There was
moderate, focal nuclear pleomorphism but no necrosis.
In several areas, entrapped proliferating bile ducts were
noted, and on biopsy, this gave an erroneous diagnosis of
well-differentiated adenocarcinoma (Figure 4).
Immunohistochemical analysis revealed strong, dif-
fuse reactivity of the spindle cells for CD34, Bcl-2 and
CD99. CEA, CK7, AE1/3, CAM 5.2, CA19.9, CD117, CK20,
desmin and smooth muscle actin were negative. This
immunohistochemical phenotype in conjunction with the
morphological features were considered to be diagnostic
of a SFT.
Discussion
Reports of SFT in the liver are scarce. To the best of our
knowledge, only 28 previous cases have been reported in
the literature.9 This uncommon occurrence and the diverse
spectrum of clinical and histopathological features make
SFT a difficult tumour to diagnose preoperatively.
SFTs may be found incidentally (as in this case), or more
usually, patients present with nonspecific symptoms of
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Figure 1. (A) Glands embedded in a spindle cell stroma (haematoxylin & eosin, 400×). (B) Glands adjacent to spindle cell proliferation
(haematoxylin & eosin, 400×).
Figure 2. Computed tomography of the abdomen, with an
arrow pointing at the lesion.
Figure 3. Computed tomography image, with arrows pointing
at the junction between the tumour and normal liver.
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vague upper abdominal pain, fatigue and weight loss.
Preoperative axial imaging generally reveals a heteroge-
neously enhancing and well-encapsulated mass, which is
suggestive of lesions such as SFT, sarcoma, leiomyoma,
sclerosed haemangioma and inflammatory pseudotumour
of the liver.3 Histopathological features of the tumour
described in this case are typical of SFTs described else-
where (bland spindle cells arranged in a patternless manner,
admixed with collagen with a low mitotic index). Although
characteristic, these observations are still nonspecific and
insufficient to constitute a conclusive diagnosis, as the
lack of pattern cannot exclude other morphologically
similar tumours.3 In recent years, developments in, and
increased use of immunohistochemistry, have allowed
elucidation of these tumours, and the consensus is that
histopathology in conjunction with immunohistochemistry
are the gold standard in confirming the diagnosis of SFT
(Table). This approach has resulted in greater identification
of SFTs.
Review of the literature suggests that intrathoracic
SFTs have a local recurrence and distant metastasis rate
of up to 15%, twice that of extrathoracic SFTs (6%).8 One
case of SFT of the liver, with bone metastasis, has been
reported.1 Common markers of aggressive behaviour 
are focal hypercellularity, high mitotic counts (> 4/hpf),
nuclear atypia and variable CD34 expression.1,3 These his-
tological factors are, however, subjective, and currently, no
unifying criteria exist for the diagnosis of malignant SFT.
Fine-needle biopsy under radiological guidance has
been frequently used in the diagnosis of isolated solid
liver lesions,2,3,5,6,8,9 but this practice is not recommended.
Large solid lesions of the liver (irrespective of the diagnosis),
if deemed resectable at pre- and intraoperative assessment,
Table. Immunophenotype of solitary fibrous tumours
Immunohistochemical marker Result
CD34 Positive
Bcl-2 Positive
Vimentin Positive
CD99 Usually positive
S100 protein Negative
Cytokeratin Negative
Muscle-specific actin Usually negative
Smooth-muscle actin Usually negative
Desmin Usually negative
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Figure 4. (A) Some residual hepatocytes entrapped
within the spindle cell proliferation (haematoxylin &
eosin, 200×). (B) Cellular spindle-shaped tumour cells
arranged in a patternless manner (haematoxylin & eosin,
200×). (C) Immunohistochemical staining shows diffuse
positive staining for CD34 (200×).
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should be excised and the specimen sent for histological
examination. Specimens obtained from fine-needle biopsy
are only representative of a very small area of the tumour,
and as in the present case, may be misleading when en-
trapped proliferating bile ducts are mistaken for adeno-
carcinoma. Alternatively, malignant foci may be missed,
giving a falsely reassuring result. Moreover, should the
tumour be malignant, percutaneous biopsy carries the
risk of seeding tumour cells along the biopsy tract.
In conclusion, margin-negative liver resection should
be the treatment of choice for large, solitary liver tumours.
Preoperative biopsy is not advocated as it is subject to
sampling error and risks seeding of tumour cells.
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